MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells

PLoS Genetics

Volumn 8, Issue 6, 2012, Pages

  Liu, Suling ^a   Patel, Shivani H ^a   Ginestier, Christophe ^b   Ibarra, Ingrid ^c   Martin Trevino, Rachel ^a   Bai, Shoumin ^a   McDermott, Sean P ^a   Shang, Li ^a   Ke, Jia ^a   Ou, Sing J ^a   Heath, Amber ^a   Zhang, Kevin J ^a   Korkaya, Hasan ^a   Clouthier, Shawn G ^a   Charafe Jauffret, Emmanuelle ^b   Birnbaum, Daniel ^b   Hannon, Gregory J ^c   Wicha, Max S ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; MICRORNA; MICRORNA 93; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; MCM7 PROTEIN, HUMAN; NUCLEAR PROTEIN;

AKT3 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER STAGING; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FATE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EZH1 GENE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HMGA2 GENE; HUMAN; HUMAN CELL; JAK1 GENE; MCM7 GENE; MOUSE; NONHUMAN; REGULATOR GENE; REGULATORY MECHANISM; SOX4 GENE; STAT3 GENE; TUMOR GENE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; CELL TRANSFORMATION; CYTOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; MAMMARY GLAND; METABOLISM; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; MICE; MICRORNAS; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS;

EID: 84864026356     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002751     Document Type: Article

References (36)

1. Petrocca F, Vecchione A, Croce CM, (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68: 8191-8194.
2. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
3. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
4. Bandres E, Agirre X, Ramirez N, Zarate R, Garcia-Foncillas J, (2007) MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 26: 273-282.
5. Hernando E, (2007) microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 9: 155-160.
6. Negrini M, Ferracin M, Sabbioni S, Croce CM, (2007) MicroRNAs in human cancer: from research to therapy. J Cell Sci 120: 1833-1840.
7. Wiemer EA, (2007) The role of microRNAs in cancer: no small matter. Eur J Cancer 43: 1529-1544.
8. Wijnhoven BP, Michael MZ, Watson DI, (2007) MicroRNAs and cancer. Br J Surg 94: 23-30.
9. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
10. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, et al. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603.
11. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, et al. (2008) The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764.
12. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, et al. (2010) Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29.
13. Xu Y, Fang F, Zhang J, Josson S, St Clair WH, et al. (2010) miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS ONE 5: e14356 doi:10.1371/journal.pone.0014356.
14. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
15. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67 (3): 1030-1037.
16. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer research 63 (18): 5821-5828.
17. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Therapeutic resistance and tumor-initiation: Molecular pathways involved in breast cancer stem cell self-renewal. J Natl Cancer Inst in press.
18. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
19. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E, (2007) let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
20. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, et al. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-1313.
21. Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hannon GJ, (2007) A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 21: 3238-3243.
22. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
23. Liu S, Wicha MS, (2010) Targeting breast cancer stem cells. J Clin Oncol 28: 4006-4012.
24. Prat A, Parker JS, Karginova O, Fan C, Livasy C, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.
25. Fillmore CM, Kuperwasser C, (2008) Human breast cancer cell lines contain stem-like cells with the capacity to self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25.
26. Akhurst RJ, Balmain A, (1999) Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol 187: 82-90.
27. Barrack ER, (1997) TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31: 61-70.
28. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, et al. (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913.
29. Wicha MS, Liu S, Dontu G, (2006) Cancer Stem Cells: An Old Idea- A Paradigm Shift. Cancer Research 66: 1883-1890.
30. Li Z, Yang CS, Nakashima K, Rana TM, (2011) Small RNA-mediated regulation of iPS cell generation. EMBO J 30: 823-834.
31. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
32. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527.
33. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, et al. (2004) Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast cancer research: BCR 6 (6).
34. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66 (12): 6063-6071.
35. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 4: 249-264.
36. Mizutani K, Sud S, McGregor NA, Martinovski G, Rice BT, et al. (2009) The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 11: 1235-1242.